evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's Nordisk: Intense Competition Within GLP-1 Duopoly (NYSE:NVO) Novo Nordisk vs Eli Lilly:

Iran J Biotechnol 13(2):19 Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O (2020) Therapeutic nanoparticles and their targeted delivery applications

Since weight loss is considered a lifestyle choice rather than a medical necessity, many insurance companies wont cover it unless its prescribed to manage a chronic health condition like type 2 diabetes

Prokopiuk V, Yefimova S, Onishchenko A, Kapustnik V, Myasoedov V, Maksimchuk P, et al

View Study [5]"Initiation of human melanocyte culture through melanocortin-1 receptor with the use of an alpha-MSH analogue" Abdel-Malek Z, Scott MC, Suzuki I, et al., 1999 Finding: This research helped explain how MT-2 works at the cellular level, showing that melanocortin receptor activation leads to increased melanin synthesis in human melanocytes